ABUS 8-K 2026-07-16

Arbutus Biopharma Corp (ABUS) 8-K dated 2026-07-16 — accession 0001171843-26-004708. This URL is the filing, not the ABUS hub.

Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.

Arbutus Biopharma Corp filed a 8-K on 2026-07-16. Accession 0001171843-26-004708.

Cached items: 1.02, 5.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABUS revenue for 2026-06-30 was $180.1M. Net income was $164.6M. Revenue was up 0.6% from 2026-03-31 to 2026-06-30. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.

Not investment advice. The ABUS SEC hub lists recent forms. The stock page is the research view.